Literature DB >> 8291116

Risk factors predicting chronic rejection of renal allografts.

H Isoniemi1, M Nurminen, M J Tikkanen, E von Willebrand, L Krogerus, J Ahonen, B Eklund, K Höckerstedt, K Salmela, P Häyry.   

Abstract

Chronic rejection is clinically defined as a gradual but progressive impairment of renal allograft function in the absence of other specific causes. The risk factors predisposing to chronic rejection are incompletely known. In this prospective single-center project, logistic regression analysis was used to study the long-term outcome of 94 consecutive first renal allografts in relation to 10 potential risk factors. Whether serum lipid levels, histopathological changes or the mode of immunosuppressive therapy had a predictive value for chronic rejection was of special interest. The risk factors for renal allograft outcome were determined 2 years after the transplantation, when graft function was still normal, and the results were evaluated 2 years later. Occurrence of acute rejections, cold ischemia time, the high-density lipoprotein cholesterol level, and the high-density lipoprotein and total cholesterol ratio were not significant predictors of graft outcome. In a univariate analysis, triglyceride, total cholesterol, and low-density lipoprotein cholesterol level, and donor age were significantly related to graft outcome. In a logistic regression analysis, triple immunosuppressive therapy was better than any double-drug regimen in preventing the deterioration of renal allografts. Incipient histological changes in graft biopsy, quantitated as the "chronic allograft damage index," was the most important single predictor of chronic rejection. The effect of both the histological changes and low-density lipoprotein cholesterol on adverse graft outcome was level dependent.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8291116     DOI: 10.1097/00007890-199401000-00013

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  16 in total

Review 1.  Calcineurin inhibitors and post-transplant hyperlipidaemias.

Authors:  R Moore; D Hernandez; H Valantine
Journal:  Drug Saf       Date:  2001       Impact factor: 5.606

Review 2.  HMG-CoA reductase inhibitors and the kidney.

Authors:  Vito M Campese; Bassel Hadaya; Josephine Chiu
Journal:  Curr Hypertens Rep       Date:  2005-10       Impact factor: 5.369

Review 3.  Chronic rejection and late renal allograft dysfunction.

Authors:  J Laine; C Holmberg; P Häyry
Journal:  Pediatr Nephrol       Date:  1996-04       Impact factor: 3.714

4.  Potential cardiovascular risk factors in paediatric renal transplant recipients.

Authors:  Jorge R Ferraris; Lidia Ghezzi; Gabriel Waisman; Rafael T Krmar
Journal:  Pediatr Nephrol       Date:  2005-10-27       Impact factor: 3.714

5.  Dyslipidaemia and hyperlipidaemia following renal transplantation.

Authors:  L Lócsey; L Asztalos; Z Kincses; F Gyórfi; C Berczi
Journal:  Int Urol Nephrol       Date:  1996       Impact factor: 2.370

Review 6.  Combating chronic renal allograft dysfunction : optimal immunosuppressive regimens.

Authors:  Pierre Merville
Journal:  Drugs       Date:  2005       Impact factor: 9.546

Review 7.  Acceleration of allograft failure by cytomegalovirus.

Authors:  Daniel N Streblow; Susan L Orloff; Jay A Nelson
Journal:  Curr Opin Immunol       Date:  2007-08-22       Impact factor: 7.486

8.  Prevalence and risk factors for early chronic allograft nephropathy in a live related renal transplant program.

Authors:  Hamid Khan; Muhammed Mubarak; Tahir Aziz; Ejaz Ahmed; Syed Fazal Akhter; Javed Kazi; Syed Aa Naqvi; Syed Ah Rizvi
Journal:  J Nephropathol       Date:  2014-04-01

9.  Diet does not explain the high prevalence of dyslipidaemia in paediatric renal transplant recipients.

Authors:  Arja Siirtola; Suvi M Virtanen; Marja Ala-Houhala; Anna-Maija Koivisto; Tiina Solakivi; Terho Lehtimäki; Christer Holmberg; Marjatta Antikainen; Matti K Salo
Journal:  Pediatr Nephrol       Date:  2007-11-15       Impact factor: 3.714

Review 10.  The pathogenesis and treatment of chronic allograft nephropathy.

Authors:  Can Li; Chul Woo Yang
Journal:  Nat Rev Nephrol       Date:  2009-07-28       Impact factor: 28.314

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.